Author Correction: Subgroup analyses from the phase 3 ASCENT study of sacituzumab govitecan in metastatic triple-negative breast cancer.
Sara Alsterlind HurvitzAditya BardiaKevin PunieKevin M KalinskyLisa Anne CareyHope S RugoVéronique DiérasSee PhanRosemary DelaneyYanni ZhuSara M TolaneyPublished in: NPJ breast cancer (2024)